| 分子名 |
货号 |
物种 |
表达系统 |
产品描述 |
纯度 |
特性 |
包装/价格 |
| Nucleocapsid protein
|
NUN-CH15
|
 Mouse
|
CHO
|
Anti-SARS-CoV-2 Nucleocapsid Antibody, Chimeric mAb, Human IgG1 (AM223) (MALS verified)
|
|
|
|
CD20
真核系统表达，完整构象
|
CD0-M36
|
Mouse
|
HEK293
|
Rituximab biosimilar–Research Grade (MALS verified)
|
|
|
|
| Nucleocapsid protein
|
NUN-CH14
|
 Human
|
CHO
|
Anti-SARS-CoV-2 Nucleocapsid Antibody, Human IgG1 (AS95) (MALS verified)
|
|
|
|
| Spike NTD
|
SPD-M121
|
Mouse
|
HEK293
|
Anti-SARS-CoV-2 Spike NTD Antibody, Chimeric mAb, Human IgG1 (AM121)
|
|
|
|
| IFN-gamma
|
IFN-PFM412
|
Human
|
HEK293
|
PE-Labeled Monoclonal Anti-IFN-gamma Antibody, human IgG1 (8C5F8)
|
|
|
|
| IFN-gamma
|
IFN-M414
|
Mouse
|
HEK293
|
Monoclonal Anti-IFNγ Antibody, Human IgG1 (13E6H6)
|
|
|
|
| IFN-gamma
|
IFN-M412
|
Mouse
|
HEK293
|
Monoclonal Anti-IFNγ Antibody, Human IgG1 (8C5F8)
|
|
|
|
| IFN-gamma
|
IFN-M411
|
Mouse
|
HEK293
|
Monoclonal Anti-IFNγ Antibody, Human IgG1 (13E6H4)
|
|
|
|
| IFN-gamma
|
IFN-BM411
|
Mouse
|
HEK293
|
Biotinylated Monoclonal Anti-IFNγ Antibody, Human IgG1 (13E6H4) (MALS verified)
|
|
|
|
| IFN-gamma
|
IFN-BLM412
|
Mouse
|
HEK293
|
Biotinylated Monoclonal IFN-gamma Antibody, Human IgG1 (8C5F8)
|
|
|
|
| TNF-alpha
|
TNA-PFM494
|
Human
|
HEK293
|
PE-Labeled Monoclonal Anti-TNF-alpha Antibody, human IgG1 (16H5) (0.03% Proclin)
|
|
|
|
| TNF-alpha
|
TNA-AM493
|
Mouse
|
HEK293
|
Monoclonal Anti-TNF-alpha Antibody, Human IgG1 (13B8) (MALS verified)
|
|
|
|
| TNF-alpha
|
TNA-AM494
|
Mouse
|
HEK293
|
Monoclonal Anti-TNF-alpha Antibody, Human IgG1 (16H5) (MALS verified)
|
|
|
|
| TNF-alpha
|
TNA-BLM494
|
Mouse
|
HEK293
|
Biotinylated Monoclonal Anti-TNF-alpha Antibody, human IgG1 (16H5) (MALS verified)
|
|
|
|
| Neuraminidase (NA)
|
NEE-MY2069
|
Mouse
|
HEK293
|
Monoclonal Anti-Influenza A virus NA (H1N1) (Victoria/2570/2019) Antibody, Human IgG1 (8E5) (MALS verified)
|
|
|
|
CD20
真核系统表达，完整构象
|
CD0-M36A2
|
Mouse
|
HEK293
|
Rituximab biosimilar, premium grade
|
|
|
|
| Nucleocapsid protein
|
NUN-M507
|
Human
|
HEK293
|
Anti-SARS-CoV-2 Nucleocapsid Antibody-A5134, Human IgG1 (Trehalose free) (MALS verified)
|
|
|
|
| Nucleocapsid protein
|
NUN-BM272
|
Mouse
|
HEK293
|
Biotinylated Anti-SARS-CoV-2 Nucleocapsid Antibody, Chimeric mAb, Human IgG1 (AM223) (MALS verified)
|
|
|
|
| Spike RBD
|
SPD-M265
|
Human
|
HEK293
|
Anti-SARS-CoV-2 Spike RBD Broadly Neutralizing Antibody, Human IgG1 (AM359b) (MALS verified)
|
|
|
|
| Spike RBD
|
SPD-M180
DMF
|
Human
|
HEK293
|
Anti-SARS-CoV-2 RBD Potent Neutralizing Antibody, Human IgG1 (AM180)
|
|
|
|
| Spike RBD
|
SPD-M370
|
Human
|
HEK293
|
Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AM110) (Delta Specific)
|
|
|
|
| Spike RBD
|
SPD-M415
|
Human
|
HEK293
|
Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AS113) (Omicron Specific)
|
|
|
|
| Spike RBD
|
SPD-PM226
|
Mouse
|
HEK293
|
PE-Labeled Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgG1 (AM122) (Site-specific conjugation)
|
|
|
|
| Spike RBD
|
S1N-M122
|
Mouse
|
HEK293
|
Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgG1 (AM122)
|
|
|
|
| Spike RBD
|
S1N-M130
|
Mouse
|
HEK293
|
Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AM130)
|
|
|
|
| Spike RBD
|
SPD-M541
|
Mouse
|
HEK293
|
Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (10B1A5) (BA.2&BA.4&BA.5/Omicron Specific) (MALS verified)
|
|
|
|
| Spike RBD
|
SPD-M540
|
Mouse
|
HEK293
|
Anti-SARS-CoV-2 Spike Broadly Antibody, Human IgG1 (2G7F5) (MALS verified)
|
|
|
|
| Spike RBD
|
S1N-M13A1
|
Mouse
|
HEK293
|
Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AM130) (Trehalose free) (MALS verified)
|
|
|
|
| Spike RBD
|
S1N-M12A1
|
Mouse
|
HEK293
|
Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgG1 (AM122) (Trehalose free)
|
|
|
|
| Spike RBD
|
S1N-M13L3
|
Mouse
|
HEK293
|
Biotinylated Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AM130) (MALS verified)
|
|
|
|
Star Ribbon预染蛋白Marker蛋白质标记物是生物研究和药物开发的重要组成部分。无论是用于蛋白质电泳还是western blot，我们的预染色蛋白质标记物帮助您快速确定目标蛋白质的分子量或评估转移效率。Fc受体蛋白治疗性抗体的功效取决于Fab片段及其对目标抗原的结合活性，还取决于Fc片段及其与关键Fc受体的相互作用。因此，在抗体工程中候选物必须针对一系列受体进行测试。探索我们的重组Fc受体蛋白质的全面收藏！
膜杰作
Star Staining
